Antitumor triptycene analogs directly interact with isolated mitochondria to rapidly trigger markers of permeability

Elisabeth M Perchellet1, Yang Wang, Kaiyan Lou

  • 1Anti-Cancer Drug Laboratory, Division of Biology, Ackert Hall, Kansas State University, Manhattan, KS 66506-4901, USA.

Anticancer Research
|November 1, 2007
PubMed
Abstract

Insights

Substituted triptycenes (TTs) trigger mitochondrial permeability transition (MPT) by directly opening the permeability transition pore (PTP). This mitochondriotoxic effect correlates with their potent anticancer activity, suggesting new therapeutic strategies.

Area of Science:

  • Mitochondrial biology
  • Cancer therapeutics
  • Molecular pharmacology

Background:

  • Substituted triptycenes (TTs) exhibit potent anticancer properties by inhibiting proliferation and inducing apoptosis.
  • TTs rapidly collapse mitochondrial transmembrane potential, but the precise mechanism beyond depolarization was unclear.
  • Investigating TTs' direct impact on mitochondrial permeability transition (MPT) is crucial for understanding their antitumor effects.

Purpose of the Study:

  • To determine if antitumor substituted triptycenes (TTs) directly induce mitochondrial permeability transition (MPT) in isolated mitochondria.
  • To elucidate the mechanism by which TTs trigger MPT and its relation to their antiproliferative activity.

Main Methods:

  • Assay of large amplitude swelling and Ca2+ release in isolated mitochondria to detect TT-induced MPT.
  • Concentration- and time-dependent studies of TT effects on mitochondria.
  • Evaluation of MPT markers and inhibition by known permeability transition pore (PTP) blockers.

Main Results:

  • Antitumor TTs induced mitochondrial swelling and Ca2+ release in a concentration- and time-dependent manner, correlating with antiproliferative activity.
  • The MPT induction by TTs was comparable to established inducers like alamethicin and atractyloside.
  • TT-induced MPT events were sensitive to calcium, ruthenium red, cyclosporin A, ADP, bongkrekic acid, and ubiquinones, indicating interaction with the PTP.

Conclusions:

  • Antitumor TTs directly trigger MPT in isolated mitochondria, likely by interacting with PTP components.
  • TTs may enhance the Ca2+-sensitive transition of the PTP from closed to open states.
  • These findings support the development of mitochondriotoxic drugs targeting the PTP for cancer therapy.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...